Publications by authors named "Guang Tu"

Claim this Profile
R
Relationship between GLR and 28-day all-cause mortality in patients with hypertensive heart disease complicated by heart failure: A retrospective analysis of the MIMIC-IV database.
Chunyan Wang, Zhonglan Cai, Shengnan Xue, Guang Tu

Medicine (Baltimore)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between blood urea nitrogen and 28-day all-cause mortality in patients with acute pulmonary edema: a retrospective analysis of the MIMIC-IV database.
Guang Tu, Yuwen Liu, Xiaomi Huang, Yanfang Zeng, Zhonglan Cai

Front Cardiovasc Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a nomogram diagnostic model for sleep disorders in stroke patients: A cross-sectional study.
Yu-Hong Zhou, Guang Tu, Yan Wu, Juan Wu, Lei Shen

Medicine (Baltimore)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between anion gap and 28-day all-cause mortality in patients with acute pulmonary edema: A retrospective analysis of the MIMIC-IV database.
Ping Guo, Yuwen Liu, Xiaomi Huang, Yanfang Zeng, Zhonglan Cai, Guang Tu

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting in-hospital mortality in ICU patients with Coronary heart disease and diabetes mellitus using machine learning models.
Guang Tu, Zhonglan Cai, Ling Wu, Hang Yu, Hongke Jiang

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting in-hospital mortality in ICU patients with lymphoma using machine learning models.
Ling Xu, Guang Tu, Zhonglan Cai, Tianbi Lan

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a nomogram diagnostic model for coronary slow flow patients: A cross-sectional study.
Guang Tu, Chen Zhao, Zhong-Lan Cai, Xiao-Mi Huang, Sui-Yang Tong

Medicine (Baltimore)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand-Blocking and Membrane-Proximal Domain Targeting Anti-OX40 Antibodies Mediate Potent T Cell-Stimulatory and Anti-Tumor Activity.
Pamela Zhang, Guang Huan Tu, Jie Wei, Pamela Santiago, Lance R Larrabee

Cell Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector/memory CD8 T cells in a poorly immunogenic tumor model.
Shihao Chen, Li-Fen Lee, Timothy S Fisher, Bart Jessen, Mark Elliott, Guang Huan Tu

Cancer Immunol Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.
Li-Fen Lee, Kathryn Logronio, Guang Huan Tu, Wenwu Zhai, Irene Ni

Proc Natl Acad Sci U S A· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis.
Li-Fen Lee, Robert Axtell, Guang Huan Tu, Kathryn Logronio, Jeanette Dilley

Sci Transl Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy.
Minh C Nguyen, Guang Huan Tu, Kathryn E Koprivnikar, Melissa Gonzalez-Edick, Karin U Jooss

Cancer Immunol Immunother· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.
B Douglas Smith, Yvette L Kasamon, Jeanne Kowalski, Christopher Gocke, Kathleen Murphy, Guang Haun Tu

Clin Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo.
Jianmin Fang, Saili Yi, Andrew Simmons, Guang Huan Tu, Minh Nguyen

Mol Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
JianMin Lin, Alshad S Lalani, Thomas C Harding, Melissa Gonzalez, Wei-Wei Wu, Guang Huan Tu

Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable antibody expression at therapeutic levels using the 2A peptide.
Jianmin Fang, Jing-Jing Qian, Saili Yi, Thomas C Harding, Guang Huan Tu

Nat Biotechnol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis